Výsledky vyhledávání - "Eugene Zhorov"

Assessment of phosphate binding by sevelamer carbonate powder for oral suspension mixed in foods

Autor: Martin, Hanus, Eugene, Zhorov, Deborah, Brommage, Melissa, Plone, Stephen Randall, Holmes-Farley

Publikováno v: Nephrology nursing journal : journal of the American Nephrology Nurses' Association. 39(3)

This study investigated mixing sevelamer carbonate powder with foods and beverages other than water. Food samples, including applesauce, oatmeal, chicken, protein powder, scrambled eggs, ginger ale, and diet ginger ale, were subjected to an in vitro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3b6de4a89a07a8a989286189cd01ebb9
https://pubmed.ncbi.nlm.nih.gov/22866363

Zobrazit plný text záznamu

Novel dosage forms and regimens for sevelamer-based phosphate binders

Autor: Martin Hanus, Eugene Zhorov, Rafif Dagher, Melissa Plone, Jeffrey M. Goldberg, Steven K. Burke, Ajay Duggal

Publikováno v: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 16(3)

Sevelamer, a nonabsorbed, calcium- and metal-free dietary phosphate binder, consists of a polyallylamine polymer backbone with a cationic charge that shows a high capacity for binding anionically charged compounds such as phosphate. The currently lic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3618e01e676b2f3c7f4e8f67a88d5845
https://pubmed.ncbi.nlm.nih.gov/16825030

Zobrazit plný text záznamu

Determination of the binding parameter constants of Renagel capsules and tablets at pH 7 by high performance capillary electrophoresis

Autor: Aharon Cohen, Eugene F. Barry, Ted Sybertz, Eugene Zhorov, Ronald A. Swearingen

Publikováno v: Journal of pharmaceutical and biomedical analysis. 35(4)

Sevelamer hydrochloride is a cross-linked polymeric amine; it is the active ingredient in Renagel ® capsules and tablets. Sevelamer hydrochloride is indicated for the control of hyperphosphatemia in patients with end-stage renal disease (ESRD). The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::723a594af462691281995859f21343dd
https://pubmed.ncbi.nlm.nih.gov/15193719

Zobrazit plný text záznamu

Bile acid binding to sevelamer HCl

Autor: Qiuwei Xu, Patrick Hook, William Braunlin, Amy Guo, S. Randall Holmes-Farley, William Apruzzese, Eugene Zhorov, David L. Smisek, W. Harry Mandeville

Publikováno v: Kidney international. 62(2)

Bile acid binding to sevelamer HCl. Background Clinical studies have shown sevelamer HCl (Renagel®) to be effective for the reduction of serum phosphate in hemodialysis patients. These studies also consistently have demonstrated a significant reduct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::506cfcbdeead705c177d6223fe63cc5a
https://pubmed.ncbi.nlm.nih.gov/12110025

Zobrazit plný text záznamu

Determination of the binding parameter constants of Renagel capsules and tablets utilizing the Langmuir approximation at various pH by ion chromatography

Autor: Ronald A. Swearingen, John S Petersen, Donghui Wang, Kristine S Riley, Xi Chen, Eugene Zhorov

Publikováno v: Journal of pharmaceutical and biomedical analysis. 29(1-2)

Sevelamer hydrochloride is a cross-linked polymeric amine; it is the active ingredient in Renagel® capsules and tablets. Sevelamer hydrochloride is indicated for the control of hyperphosphatemia in patients with end-stage renal disease. The binding

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f3c6f178184f50c2380a37ced0b32c
https://pubmed.ncbi.nlm.nih.gov/12062678

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání